The latest thoracic oncology news
Antibody targets tumour-promoting molecules deep within cancer cells
A new study published in Immunity, a Cell Press journal, unveils an approach to cancer…
Browsing: Lung Cancer
Lung cancer outcomes significantly improved with immunotherapy-based treatment given before and after surgery
A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival…
Lung cancer cells can thrive in the brain by recruiting astrocytes for protection
Lung cancer cells that metastasize to the brain survive by convincing brain cells called astrocytes…
Amivantamab plus chemo with or without lazertinib reduced risk of disease progression or death for EGFR-mutated NSCLC
The results from the Phase 3 MARIPOSA study were announced showing amivantamab-vmjw in combination with…
ESMO 2023: Amivantamab plus chemo with or without lazertinib reduced risk of disease progression or death for EGFR-mutated NSCLC
The results from the Phase 3 MARIPOSA-2 study have been announced showing the regimen of…
ESMO 2023: Lung cancer treatment research enters a new era
More people with non-small cell lung cancer (NSCLC) are likely to benefit from new drugs…
ESMO 2023: Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer
Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery…
Researchers pinpoint nongenetic mechanisms in lung cancer resistance to one commonly used therapy
In a recent study led by Ravi Salgia, M.D., Ph.D., the Arthur & Rosalie Kaplan…
Research finds non-small cell lung cancer drug lorlatinib targets additional protein
Targeted cancer drugs are widely used because of their ability to inhibit specific proteins involved…